Vicarious Surgical (RBOT) Cost of Revenue (2020 - 2025)
Vicarious Surgical (RBOT) reported Cost of Revenue of $350000.0 for Q3 2025, down 71.03% year-over-year from $1.2 million in Q3 2024, and little changed on a QoQ basis from $349000.0 in Q2 2025.
Vicarious Surgical (RBOT) has 6 years of Cost of Revenue data on file, last reported at $350000.0 in Q3 2025.
- Quarterly Cost of Revenue fell 71.03% year-over-year to $350000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.7 million (down 42.75% YoY) and the FY2024 annual result came in at $4.5 million, down 27.37% from the prior year.
- Cost of Revenue held at $350000.0 in Q3 2025 per RBOT's latest filing, from $349000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $2.0 million in Q1 2023 and bottomed at $226000.0 in Q1 2021.
- The 5-year median for Cost of Revenue is $1.2 million (2023), against an average of $1.2 million.
- The widest annual swing landed in 2021, when Cost of Revenue jumped 1744.71%; it then slumped 71.03% in 2025.
- Tracing RBOT's Cost of Revenue over 5 years: stood at $1.6 million in 2021, then advanced by 17.22% to $1.8 million in 2022, then slumped by 34.55% to $1.2 million in 2023, then declined by 18.62% to $979000.0 in 2024, then slumped by 64.25% to $350000.0 in 2025.
- Per Business Quant, the three latest RBOT Cost of Revenue figures stand at $350000.0 (Q3 2025), $349000.0 (Q2 2025), and $1.0 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 441.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 481.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 891.20 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 350,000.00 |
| Sep 30, 2025 | 350,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Mar 31, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 979,000.00 |
| Dec 31, 2024 | 979,000.00 |
| Sep 30, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | 842,000.00 |
| Sep 30, 2021 | 842,000.00 |
| Jun 30, 2021 | 325,000.00 |
| Jun 30, 2021 | 325,000.00 |
| Mar 31, 2021 | 226,000.00 |
| Mar 31, 2021 | 226,000.00 |
| Dec 31, 2020 | 85,000.00 |
| Dec 31, 2020 | 85,000.00 |
| Sep 30, 2020 | 362,000.00 |
| Sep 30, 2020 | 362,000.00 |